OMMH Stock Chart & Stats
$0.01
--
At close: 4:00 PM EDT
$0.01
--
Day’s Range― - ―
52-Week Range$0.01 - $0.01
Previous CloseN/A
VolumeN/A
Average Volume (3M)0.00
Market Cap
$981.00
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding9,807,421
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.00
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
OMMH FAQ
What was Omnimmune Holdings Inc’s price range in the past 12 months?
Omnimmune Holdings Inc lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
What is Omnimmune Holdings Inc’s market cap?
Omnimmune Holdings Inc’s market cap is $981.00.
When is Omnimmune Holdings Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Omnimmune Holdings Inc’s earnings last quarter?
Currently, no data Available
Is Omnimmune Holdings Inc overvalued?
According to Wall Street analysts Omnimmune Holdings Inc’s price is currently Overvalued.
Does Omnimmune Holdings Inc pay dividends?
Omnimmune Holdings Inc does not currently pay dividends.
What is Omnimmune Holdings Inc’s EPS estimate?
Omnimmune Holdings Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Omnimmune Holdings Inc have?
Omnimmune Holdings Inc has 9,807,421 shares outstanding.
What happened to Omnimmune Holdings Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Omnimmune Holdings Inc?
Currently, no hedge funds are holding shares in OMMH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Omnimmune Holdings Inc
Omnimmune Holdings, Inc., through its subsidiary, Omnimmune Corp., operates as a development-stage biotechnology company integrating complementary cancer therapeutic, diagnostic, and prognostic technologies in the United States. The company owns rights for monoclonal antibody technologies. It also intends to develop personalized cancer treatment with the selection of prophylactic and therapeutic vaccines (active immunization), monoclonal antibodies (passive immunization), and genomic-based products, which target a hormone called human chorionic gonadotropin. In addition, the company plans to conduct a Phase I trial with its lead candidate anti-human chorionic gonadotropin beta subunit monoclonal antibodies based upon the results of the diagnostic trial. Omnimmune Holdings, Inc. is based in Houston, Texas.